Sino Biopharmaceutical Limited

SBMFF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$3,500$5,934$5,779$18,573
Dep. & Amort.$1,321$1,074$1,047$993
Deferred Tax$0$0$0$0
Stock-Based Comp.$54$18$30$0
Change in WC$27-$431-$196-$339
Other Non-Cash$1,713-$530-$395-$13,860
Operating Cash Flow$6,615$6,066$6,265$5,366
Investing Activities
PP&E Inv.$0-$1,068-$1,706-$1,894
Net Acquisitions$0-$743-$59-$959
Inv. Purchases$0-$1,650-$4,483-$4,847
Inv. Sales/Matur.$0$2,561$1,079$903
Other Inv. Act.-$1,709$142$1,097$4,280
Investing Cash Flow-$1,709-$757-$4,071-$2,516
Financing Activities
Debt Repay.-$2,779-$1,754$1,049-$1,638
Stock Issued$0$0$0$0
Stock Repurch.-$1,252-$396-$868-$333
Dividends Paid-$1,846-$633-$1,268-$938
Other Fin. Act.-$437-$3,766-$2,100-$316
Financing Cash Flow-$6,315-$6,549-$3,186-$3,225
Forex Effect$136$91$47-$650
Net Chg. in Cash-$1,274-$1,150-$945-$1,025
Supplemental Information
Beg. Cash$7,505$8,655$9,600$10,624
End Cash$6,232$7,505$8,655$9,600
Free Cash Flow$5,655$4,362$4,560$3,472